Danish biotech Gubra announces that Germany’s Boehringer Ingelheim has decided to discontinue the development of the long-acting neuropeptide Y receptor type 2 (NPY2R) agonist BI 1820237 in obesity.
PROVIDENCE, R.I. [Brown University] — Biologists at Brown University have discovered how a neuropeptide hormone ... such as pancreatic polypeptide Y (PPY) and glucagon-like peptide-1 (GLP ...
Experts suggest that testing for this protein, called neuropeptide Y (NPY), could help predict how heart failure is likely to progress. Researchers hope a blood test could be used to help guide ...
Experts suggest that testing for this protein, called neuropeptide Y (NPY), could help predict how heart failure is likely to progress. Researchers hope a blood test could be used to help guide ...
Biologists at Brown University have discovered how a neuropeptide hormone made in the ... such as pancreatic polypeptide Y (PPY) and glucagon-like peptide-1 (GLP-1). GLP-1 is in the same family ...
The best characterized pathways are the orexigenic neuropeptide Y/Agouti-related protein and the anorexigenic pro-opiomelanocortin/cocaine- and amphetamine-related transcript neurons in the ...
The hypothalamus integrates neurohormonal signaling from gut and adipose tissue. Specific hypothalamic nuclei, including the dorsomedial nucleus (DMN), paraventricular nucleus (PVN) and ...